Case File
efta-01956015DOJ Data Set 10OtherEFTA01956015
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01956015
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Melanie SpineIla
From:
Jeffrey Epstein
Sent
Sun 9/22/2013 1:48:40 PM
With due respect, I think a freeze partnership is far less complex than derivatives. The Code and
regulations provide a roadmap of how to structure a freeze partnership. (Please identify the
complex accounting rules that give you pause.) Further, we can unwind in the future. Derivatives,
in my view, raise gift and estate tax concerns under 2703 and corporate law issues. And GRATs,
while very effective, could lead to the very same concerns we faced earlier: Leon's lost income
flow and increasing promissory notes.
Alan S. Halperin I Partner
From: "Jeffrey Epstein" [email protected]
Sent: 09/22/2013 09:25 AM AST
To: Alan Halperin
Subject: Re:
clever,--- I am hesitant to have a partnersip with a fixed future and extremely complex
accounting and rules. There is a time component to the structures. I am also not familar with
the sec laws that might apply.
with regard the exchange of pro note for the art. I am attempting to make a distinction between
the owner of the trust and the owner of the consideration.
On Sun, Sep 22, 2013 at 9:15 AM, Alan S Halperin
wrote:
Will doL.Anitolease send nrieyourflua,
treeie art nershi ) in light of a na
. t. lh .ness to have art tied u in trust
EFTA_R1_00426590
EFTA01956015
From: "Jeffrey Epstein" [[email protected]]
Sent: 09/22/2013 07:26 AM AST
To: Alan Halperin; "Ada Clapp"
my argument is that leon is owner for fed income tax purposed of the promissory note, he owns
the consideration. and substituties the art. It cannot be recognized for sales taz as he owns
the same consideration before and after. its not that there is no consideration it is the
ownsership of that consideration did not change.
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacationOgmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00428591
EFTA01956016
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.